COVID-19, an experimental approach against the virus that has killed more than 238,000 Americans.The Food and Drug Administration on Monday cleared the experimental drug from Eli Lilly for people 12 and older with mild or moderate COVID-19 not requiring hospitalization.
It’s a one-time treatment given through an IV. Coronavirus: Eli Lilly antibody treatment trials halted due to safety concern The therapy is still undergoing additional testing to establish its safety and effectiveness.
It is similar to a treatment President Donald Trump received after contracting the virus last month.Lilly’s studies of the antibody drug are continuing.